FDA.reportPublic FDA data

gemcitabine 2 GM per 52.6 ML Injection

RxCUI
1720975
RxNorm name
gemcitabine 2 GM per 52.6 ML Injection
Display name
gemcitabine 2 GM per 52.6 ML Injection
Full name
gemcitabine 2 GM per 52.6 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GemcitabineGEMCITABINEHospira, Inc.dc02a23b-3ff9-4441-aa91-8e9e629a73152026-04-27Warnings, Adverse reactionsExact identifier
rxcui: 1720975
GemcitabineGEMCITABINEHospira, Inc.e18ed1cb-7dd0-4001-bfda-17d1f4587fb82026-04-27Warnings, Adverse reactionsExact identifier
rxcui: 1720975
GemcitabineGEMCITABINEHikma Pharmaceuticals USA Inc.d80176fe-3e8b-48be-87c2-9c603013b3fa2025-10-24Warnings, Adverse reactionsExact identifier
rxcui: 1720975
GemcitabineGEMCITABINE HYDROCHLORIDEMeitheal Pharmaceuticals Inc.c0b1b715-9ff8-43ca-9e49-465f1f3800842025-07-23Warnings, Adverse reactionsExact identifier
rxcui: 1720975
GemcitabineGEMCITABINESagent Pharmaceuticals22af3507-4b4f-4cad-9d61-89ffc4aabbc72025-02-03Warnings, Adverse reactionsExact identifier
rxcui: 1720975
GemcitabineGEMCITABINE HYDROCHLORIDEMylan Institutional LLC06dd9d40-74fc-4409-93b1-a46be71263312024-11-11Warnings, Adverse reactionsExact identifier
rxcui: 1720975
GemcitabineGEMCITABINE HYDROCHLORIDEMeitheal Pharmaceuticals Inc.73ae04d8-38f9-4d3d-b0c2-71d22af1fc862024-08-05Warnings, Adverse reactionsExact identifier
rxcui: 1720975

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 7 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
dc02a23b-3ff9-4441-aa91-8e9e629a7315gemcitabine 2 GM in 52.6 ML Injection [PSN] · 52.6 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection [SY] · gemcitabine 2 GM per 52.6 ML Injection [SY]428These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 199620260427
22af3507-4b4f-4cad-9d61-89ffc4aabbc7gemcitabine 2 GM in 52.6 ML Injection [PSN] · 52.6 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection [SY] · gemcitabine 2 GM per 52.6 ML Injection [SY]48These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 199620250203
73ae04d8-38f9-4d3d-b0c2-71d22af1fc86gemcitabine 2 GM in 52.6 ML Injection [PSN] · 52.6 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection [SY] · gemcitabine 2 GM per 52.6 ML Injection [SY]47These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 199620240805
06dd9d40-74fc-4409-93b1-a46be7126331gemcitabine 2 GM in 52.6 ML Injection [PSN] · 52.6 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection [SY] · gemcitabine 2 GM per 52.6 ML Injection [SY]46These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 199620241111
d80176fe-3e8b-48be-87c2-9c603013b3fagemcitabine 2 GM in 52.6 ML Injection [PSN] · 52.6 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection [SY] · gemcitabine 2 GM per 52.6 ML Injection [SY]44HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 199620251024
c0b1b715-9ff8-43ca-9e49-465f1f380084gemcitabine 2 GM in 52.6 ML Injection [PSN] · 52.6 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection [SY] · gemcitabine 2 GM per 52.6 ML Injection [SY]41These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 199620250723
518b9c2e-fdbe-46de-9859-02314c220d58gemcitabine 2 GM in 52.6 ML Injection [PSN] · 52.6 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection [SY] · gemcitabine 2 GM per 52.6 ML Injection [SY]41These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use. Initial U.S. Approval: 199620200104